Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NLBS | AMGN | GILD | VRTX | BIIB |
| Company | Nutralife Biosciences Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0001 | 312.89 | 64.72 | 420.67 | 222.76 |
| High | 0.0001 | 314.89 | 66.20 | 422.57 | 223.95 |
| Low | 0.0001 | 309.82 | 64.67 | 417.50 | 220.01 |
| Last | 0.0001 | 311.26 | 65.90 | 422.78 | 222.72 |
| Change | -0.0002 | -1.60 | +1.32 | +3.79 | -0.03 |
| % Change | -66.67% | -0.51% | +2.04% | +0.90% | -0.01% |
| Volume | 700 | 1,732,530 | 6,057,958 | 618,099 | 338,304 |
| 20-Day Average Volume | 15,140 | 2,884,254 | 7,472,546 | 1,084,124 | 1,310,920 |
| Previous Close | 0.0003 | 312.86 | 64.58 | 418.99 | 222.75 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0002 | 281.64 | 65.99 | 401.93 | 207.61 |
| 20-Day Raw Stochastic | 0.00% | 80.85% | 37.45% | 91.11% | 95.33% |
| 20-Day Relative Strength | 36.85% | 66.39% | 39.38% | 62.19% | 59.25% |
| Weighted Alpha | -56.12 | +34.38 | -19.44 | +22.83 | -25.61 |
| Today's Opinion | 100% Sell | 56% Buy | 100% Sell | 56% Buy | 56% Sell |
| Previous Opinion | 96% Sell | 56% Buy | 100% Sell | 56% Buy | 56% Sell |
| Last Month's Opinion | 100% Sell | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -50.00% since 12/27/23 | -0.18% since 05/03/24 | +1.69% since 05/03/24 | +5.36% since 05/03/24 | +2.22% since 05/03/24 |
| Low | 0.0001 on 03/01/24 | 297.52 on 05/06/24 | 64.34 on 05/06/24 | 394.03 on 05/07/24 | 216.08 on 05/07/24 |
| High | 0.0003 on 02/08/24 | 314.89 on 05/10/24 | 66.20 on 05/10/24 | 425.65 on 05/08/24 | 223.95 on 05/10/24 |
| 1-Month | |||||
| %Chg | -66.67% since 01/23/24 | +16.62% since 04/10/24 | -3.30% since 04/10/24 | +6.29% since 04/10/24 | +10.32% since 04/10/24 |
| Low | 0.0001 on 03/01/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.0003 on 02/08/24 | 322.60 on 05/03/24 | 69.03 on 04/11/24 | 425.65 on 05/08/24 | 223.95 on 05/10/24 |
| 3-Month | |||||
| %Chg | unch since 11/17/23 | +6.74% since 02/09/24 | -10.58% since 02/09/24 | -0.08% since 02/09/24 | -7.74% since 02/09/24 |
| Low | 0.0001 on 03/01/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.0003 on 02/08/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | -66.67% since 08/25/23 | +16.25% since 11/10/23 | -13.23% since 11/10/23 | +13.09% since 11/10/23 | -1.09% since 11/10/23 |
| Low | 0.0001 on 03/01/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 0.0003 on 02/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18 | 167,829,040 | 80,407,072 | 108,121,632 | 32,431,732 |
| Shares Outstanding, K | 180,606 | 536,435 | 1,245,077 | 258,053 | 145,597 |
| Annual Sales | 630,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -5,830,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 120,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 | 2,290,500,000 |
| Last Quarter Net Income | -1,180,000 | -113,000,000 | -4,170,000,000 | 968,800,000 | 393,400,000 |
| 60-Month Beta | -1.01 | 0.60 | 0.22 | 0.39 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 10/02/23 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 16.11 | 27.81 | 14.65 |